SOLVNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Solventum Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$85.05−0.76 (-0.89%)
Close on Oct 19, 2026
- Market cap
- $14.74B
- P/E (TTM)
- 10.4
- Dividend yield
- –
Solventum Corp revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MedSurg | $5.05B | $4.89B | $4.82B | $4.76B | $4.73B | $4.68B | $4.64B | $4.63B | $4.63B | $4.63B | $4.63B | 60.7% | +6.7% |
| Dental Solutions | $1.43B | $1.38B | $1.35B | $1.32B | $1.30B | $1.29B | $1.30B | $1.29B | $1.30B | $1.32B | $1.33B | 17.2% | +10.7% |
| Health Information Systems | $1.39B | $1.37B | $1.36B | $1.35B | $1.33B | $1.32B | $1.31B | $1.30B | $1.30B | $1.29B | $1.29B | 16.7% | +4.5% |
| Purification and Filtration | $128.00M | $317.00M | $497.00M | $674.00M | $726.00M | $775.00M | $709.00M | $893.00M | $955.00M | $965.00M | $689.00M | 1.5% | -82.4% |
| Operating income | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MedSurg | $910.00M | $765.00M | $810.00M | $828.00M | $868.00M | $872.00M | $887.00M | $956.00M | $1.02B | $1.08B | $1.11B | +4.8% |
| Health Information Systems | $542.00M | $517.00M | $496.00M | $477.00M | $448.00M | $439.00M | $431.00M | $436.00M | $445.00M | $430.00M | $423.00M | +21.0% |
| Dental Solutions | $389.00M | $354.00M | $346.00M | $334.00M | $321.00M | $318.00M | $350.00M | $370.00M | $410.00M | $441.00M | $442.00M | +21.2% |
| Purification and Filtration | $26.00M | $69.00M | $96.00M | $108.00M | $101.00M | $77.00M | $74.00M | $54.00M | $83.00M | $114.00M | $111.00M | -74.3% |
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of product | $6.30B | $6.27B | $6.35B | $6.44B | $6.46B | $6.39B | $6.35B | $6.31B | $6.30B | $6.30B | $6.30B | 75.8% | -2.5% |
| Cost of software and rentals | $2.01B | $2.00B | $1.98B | $1.96B | $1.93B | $1.92B | $1.91B | – | – | – | – | 24.2% | +4.2% |
By region
From the segment and revenue-disaggregation notes of Solventum's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.